These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1646350)

  • 21. The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e.
    Liu RY; Fan C; Mitchell S; Chen Q; Wu J; Zuckerman KS
    Cancer Res; 1998 May; 58(10):2217-23. PubMed ID: 9605769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triggering of antitumor activity through melanoma-specific transduction of a constitutively active tumor necrosis factor (TNF) R1 chimeric receptor in the absence of TNF-alpha.
    Bazzoni F; Regalia E
    Cancer Res; 2001 Feb; 61(3):1050-7. PubMed ID: 11221832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor.
    Oettgen HF; Old LJ
    Important Adv Oncol; 1987; ():105-30. PubMed ID: 2841229
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor necrosis factor: receptors and inhibitors.
    Loetscher H; Steinmetz M; Lesslauer W
    Cancer Cells; 1991 Jun; 3(6):221-6. PubMed ID: 1654969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [TNF: antitumoral agent at the border lines of immunity and inflammation].
    Branellec D; Chouaib S
    Pathol Biol (Paris); 1991 Mar; 39(3):230-9. PubMed ID: 1646993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orchestration of septic shock by cytokines: the role of cachectin (tumor necrosis factor).
    Beutler BA
    Prog Clin Biol Res; 1989; 286():219-35. PubMed ID: 2648412
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor necrosis factor-induced changes of gene expression in U937 cells. Differentiation-dependent plasticity of the responsive state.
    Schütze S; Scheurich P; Schlüter C; Ucer U; Pfizenmaier K; Krönke M
    J Immunol; 1988 May; 140(9):3000-5. PubMed ID: 2834449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vital osteoclast: how is it regulated?
    Aeschlimann D; Evans BA
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S5-7. PubMed ID: 15243577
    [No Abstract]   [Full Text] [Related]  

  • 30. How do tumor necrosis factor receptors work?
    Bazzoni F; Beutler B
    J Inflamm; 1995; 45(4):221-38. PubMed ID: 8867667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
    Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
    Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour necrosis factor signal transduction.
    Krönke M; Schütze S; Scheurich P; Meichle A; Hensel G; Thoma B; Kruppa G; Pfizenmaier K
    Cell Signal; 1990; 2(1):1-8. PubMed ID: 2176798
    [No Abstract]   [Full Text] [Related]  

  • 33. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
    Sherry B; Cerami A
    J Cell Biol; 1988 Oct; 107(4):1269-77. PubMed ID: 3049617
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties.
    Nawroth PP; Stern DM
    Onkologie; 1987 Aug; 10(4):254-8. PubMed ID: 2823200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor/cachectin as an effector of T cell-dependent immunopathology.
    Grau GE; Lambert PH; Vassalli P; Piguet PF
    Int Rev Exp Pathol; 1993; 34 Pt B():159-71. PubMed ID: 8458711
    [No Abstract]   [Full Text] [Related]  

  • 36. Cachectin: its impact on metabolism and nutritional status.
    Moldawer LL; Lowry SF; Cerami A
    Annu Rev Nutr; 1988; 8():585-609. PubMed ID: 3060179
    [No Abstract]   [Full Text] [Related]  

  • 37. Structure of tumor necrosis factor and its receptor.
    Aggarwal BB
    Biotherapy; 1991; 3(2):113-20. PubMed ID: 1647190
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytotoxic mechanism of tumor necrosis factor-alpha.
    Larrick JW; Wright SC
    FASEB J; 1990 Nov; 4(14):3215-23. PubMed ID: 2172061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha.
    Rock CS; Lowry SF
    J Surg Res; 1991 Nov; 51(5):434-45. PubMed ID: 1661798
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor necrosis factor: biology and therapeutic inhibitors.
    Papadakis KA; Targan SR
    Gastroenterology; 2000 Oct; 119(4):1148-57. PubMed ID: 11040201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.